|
EMD expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.782500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.761190E-01 |
| Normal-vs-Stage2 |
3.321600E-02 |
| Normal-vs-Stage3 |
7.464500E-03 |
| Normal-vs-Stage4 |
3.288200E-01 |
| Stage1-vs-Stage2 |
1.986850E-01 |
| Stage1-vs-Stage3 |
4.902300E-02 |
| Stage1-vs-Stage4 |
8.308400E-01 |
| Stage2-vs-Stage3 |
8.523200E-01 |
| Stage2-vs-Stage4 |
1.894400E-01 |
| Stage3-vs-Stage4 |
8.020100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.563910E-02 |
| Normal-vs-AfricanAmerican |
3.758400E-01 |
| Normal-vs-Asian |
3.628500E-02 |
| Caucasian-vs-AfricanAmerican |
1.140370E-02 |
| Caucasian-vs-Asian |
1.416650E-01 |
| AfricanAmerican-vs-Asian |
1.098300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.535700E-02 |
| Normal-vs-Female |
1.068180E-01 |
| Male-vs-Female |
5.613000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.916180E-01 |
| Normal-vs-Age(41-60Yrs) |
4.172200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.287750E-01 |
| Normal-vs-Age(81-100Yrs) |
1.408800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.753400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.786000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.290800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.780000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.244400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.108400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.764000E-01 |
| Normal-vs-Grade 2 |
4.356800E-01 |
| Normal-vs-Grade 3 |
3.756700E-03 |
| Normal-vs-Grade 4 |
1.840020E-02 |
| Grade 1-vs-Grade 2 |
5.002200E-01 |
| Grade 1-vs-Grade 3 |
6.777600E-02 |
| Grade 1-vs-Grade 4 |
1.075400E-01 |
| Grade 2-vs-Grade 3 |
5.936000E-03 |
| Grade 2-vs-Grade 4 |
4.035900E-02 |
| Grade 3-vs-Grade 4 |
8.234400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.933700E-02 |
| Normal-vs-ccB subtype |
1.898950E-03 |
| ccA subtype-vs-ccB subtype |
4.665900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.069880E-02 |
| Normal-vs-N1 |
1.991880E-02 |
| N0-vs-N1 |
2.488800E-01 |
|
|
